International Clinical Trial: A prospective, multicenter, double-blind, randomized controlled trial of early adjunctive eptifibatide following intravenous thrombolysis in acute disabling stroke due to non-large vessel occlusion

Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600120216) titled 'A prospective, multicenter, double-blind, randomized controlled trial of early adjunctive eptifibatide following intravenous thrombolysis in acute disabling stroke due to non-large vessel occlusion' on March 11.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: The Second Affiliated Hospital of Chongqing Medical University

Condition: Acute Ischemic Stroke

Intervention: Experimental group:Intravenous administration of eptifibatide+Standard medical treatment

Recruitment Status: Not Recruiting

Phase: 3

Date of First Enrollment: 2026-04-01

Target Sample Size: Experimental group:5...